GB0516295D0 - Chemical compounds - Google Patents

Chemical compounds

Info

Publication number
GB0516295D0
GB0516295D0 GB0516295A GB0516295A GB0516295D0 GB 0516295 D0 GB0516295 D0 GB 0516295D0 GB 0516295 A GB0516295 A GB 0516295A GB 0516295 A GB0516295 A GB 0516295A GB 0516295 D0 GB0516295 D0 GB 0516295D0
Authority
GB
United Kingdom
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0516295A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0516295A priority Critical patent/GB0516295D0/en
Publication of GB0516295D0 publication Critical patent/GB0516295D0/en
Priority to TW095117265A priority patent/TW200714597A/en
Priority to PCT/GB2006/001887 priority patent/WO2006125972A1/en
Priority to AU2006250985A priority patent/AU2006250985A1/en
Priority to JP2008512906A priority patent/JP2008545684A/en
Priority to CN2006800277592A priority patent/CN101233128B/en
Priority to MX2007014784A priority patent/MX2007014784A/en
Priority to US11/913,114 priority patent/US7943607B2/en
Priority to KR1020077028633A priority patent/KR20080011689A/en
Priority to CA002609235A priority patent/CA2609235A1/en
Priority to BRPI0609892-4A priority patent/BRPI0609892A2/en
Priority to EP06743964A priority patent/EP1891058A1/en
Priority to UY29562A priority patent/UY29562A1/en
Priority to ARP060102193A priority patent/AR054365A1/en
Priority to IL186865A priority patent/IL186865A0/en
Priority to NO20075626A priority patent/NO20075626L/en
Ceased legal-status Critical Current

Links

GB0516295A 2005-05-27 2005-08-09 Chemical compounds Ceased GB0516295D0 (en)

Priority Applications (16)

Application Number Priority Date Filing Date Title
GB0516295A GB0516295D0 (en) 2005-08-09 2005-08-09 Chemical compounds
TW095117265A TW200714597A (en) 2005-05-27 2006-05-16 Chemical compounds
EP06743964A EP1891058A1 (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
MX2007014784A MX2007014784A (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes.
CA002609235A CA2609235A1 (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
JP2008512906A JP2008545684A (en) 2005-05-27 2006-05-23 Compound
CN2006800277592A CN101233128B (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
PCT/GB2006/001887 WO2006125972A1 (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
US11/913,114 US7943607B2 (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
KR1020077028633A KR20080011689A (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
AU2006250985A AU2006250985A1 (en) 2005-05-27 2006-05-23 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
BRPI0609892-4A BRPI0609892A2 (en) 2005-05-27 2006-05-23 compound or a salt or prodrug thereof, pharmaceutical composition, use of a compound or a pharmaceutically acceptable salt or prodrug thereof, method for treating glk-mediated diseases, and process for preparing a compound
UY29562A UY29562A1 (en) 2005-05-27 2006-05-25 AMINO BENZOIL HETEROCYCLIC COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, PREPARATION PROCEDURES AND APPLICATIONS
ARP060102193A AR054365A1 (en) 2005-05-27 2006-05-26 DERIVED FROM HETEROARIL BENZAMIDAS, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM, USES IN DISEASES MEDIATED BY GLUCOQUINAS AND METHOD OF PREPARATION OF THE SAME.
IL186865A IL186865A0 (en) 2005-05-27 2007-10-23 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
NO20075626A NO20075626L (en) 2005-05-27 2007-11-06 Heteroberl benzamide derivatives for use as GLK activators in the treatment of diabetes

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0516295A GB0516295D0 (en) 2005-08-09 2005-08-09 Chemical compounds

Publications (1)

Publication Number Publication Date
GB0516295D0 true GB0516295D0 (en) 2005-09-14

Family

ID=34984280

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0516295A Ceased GB0516295D0 (en) 2005-05-27 2005-08-09 Chemical compounds

Country Status (1)

Country Link
GB (1) GB0516295D0 (en)

Similar Documents

Publication Publication Date Title
GB0504753D0 (en) Chemical compounds
GB0503056D0 (en) Chemical compounds
GB0511266D0 (en) Chemical compounds
GB0514018D0 (en) Chemical compounds
EP1951217A4 (en) Chemical compounds
EP1951250A4 (en) Chemical compounds
EP1919872A4 (en) Chemical compounds
GB0503053D0 (en) Chemical compounds
EP1853604A4 (en) Chemical compounds
EP1940394A4 (en) Chemical compounds
EP1959737A4 (en) Chemical compounds
EP1948187A4 (en) Chemical compounds
EP1896014A4 (en) Chemical compounds
GB0503054D0 (en) Chemical compounds
GB0510852D0 (en) Chemical compounds
GB0504475D0 (en) Chemical compounds
GB0504474D0 (en) Chemical compounds
GB0514017D0 (en) Chemical compounds
GB0507200D0 (en) Chemical compounds
GB0506886D0 (en) Chemical compounds
GB0500301D0 (en) Chemical compounds
GB0514174D0 (en) Chemical compounds
GB0511851D0 (en) Chemical compounds
GB0514173D0 (en) Chemical compounds
GB0507347D0 (en) Chemical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)